•
China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050) has announced that it has received a Class III Medical Devices Certificate from the National Medical Products Administration (NMPA) for its phakic intraocular lens, Loong Crystal PR. The approval, granted with fast-track status, allows the product to be used for treating…
•
China-based ophthalmic medical device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050), has announced plans to raise up to RMB 300 million (USD 41.3 million) through a private placement of 3,787,878 shares. The capital raised will be allocated towards the construction project of a contact lens and injection mold processing…
•
Eyebright Medical Technology Co., Ltd (SHA: 688050), a Beijing-based company specializing in ophthalmic medical devices, is poised to issue 8,420,079 Global Depository Receipts (GRDs) on the SIX Exchange, pending approval from the Swiss bourse and regulatory filing in China. The listing is anticipated to generate a take-home amount of RMB…
•
Beijing-based Eyebright Medical Technology Co., Ltd (SHE: 688050) has announced that its “intraocular lenses with crystalline eyes” have been granted fast-track status as an innovative medical device in China. This designation underscores the potential impact of the company’s technology on the field of ophthalmology. Refractive Intraocular Lenses for Myopia CorrectionThe…
•
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered into a partnership with Beijing-headquartered ophthalmic device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050). The collaboration aims to enhance the development and commercialization of ophthalmic drugs and medical devices. Comprehensive Collaboration in OphthalmologyUnder the…